Recommendations of the Spanish Society of Pediatric Cardiology and Congenital Heart Diseases for the prevention of respiratory syncytial virus infections with nirsevimab in pediatric cardiology
Saved in:
Main Authors: | Constancio Medrano López (Author), Fernando Centeno Malfaz (Author), María Garcés Sánchez (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recommendations of the Spanish Society of Neonatology for the prevention of severe respiratory syncytial virus infections with nirsevimab, for the 2024-2025 season
by: Manuel Sánchez Luna, et al.
Published: (2024) -
Recomendaciones de la Sociedad Española de Cardiología Pediátrica y Cardiopatías Congénitas sobre la profilaxis de la infección por virus respiratorio sincitial con nirsevimab en cardiología pediátrica
by: Constancio Medrano López, et al.
Published: (2024) -
Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants - Importance of design
by: Getu Zhaori
Published: (2023) -
Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain
by: Jaime Jesús Pérez Martín, et al.
Published: (2024) -
Recommendations of the Spanish Society of Paediatric Cardiology and Congenital Heart Disease as regards the use of drugs in attention deficit hyperactivity disorder in children and adolescents with a known heart disease, as well as in the general paediatric population: position statement by the Spanish Paediatric Association
by: Javier Pérez-Lescure Picarzo, et al.
Published: (2020)